Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,867 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00770354 | Phase II Study of AS1402 Combined With Letrozole to Treat Breast Cancer | terminated | Phase 2 | 110 | Antisoma ResearchINDUSTRY | 1 | Aug 10, 2009 | clinicaltrials |
| NCT00465673 | Liposomal Doxorubicin (Lipo-Dox) in Patients With Brain Metastasis From Breast Cancer | terminated | Phase 2 | 2 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 6, 2009 | clinicaltrials |
| NCT00354900 | Phase I Study of Aprotinin in Advanced Breast Cancer | terminated | Phase 1 | 18 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 4, 2009 | clinicaltrials |
| NCT00251095 | Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast Cancer | terminated | Phase 3 | 821 | Achieve Life SciencesINDUSTRY | 1 | Jun 4, 2009 | clinicaltrials |
| NCT00452140 | Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine Treatment | terminated | Phase 2 | 40 | Neovii BiotechINDUSTRY | 5 | May 19, 2009 | clinicaltrials |
| NCT00241462 | Faslodex Observations During Regular Use by Advanced Mammacarcinoma Patients(FORUM) | terminated | — | 150 | AstraZenecaINDUSTRY | 1 | Apr 22, 2009 | clinicaltrials |
| NCT00851110 | Adjuvant Breast Cancer Study of the Netherlands Working Party for Autotransplantation in Solid Tumors | terminated | Phase 2 | 50 | University Medical Center GroningenOTHER | 1 | Feb 25, 2009 | clinicaltrials |
| NCT00810706 | Adjuvant Post-Tamoxifen Exemestane Trial(ATENA) | terminated | Phase 3 | 448 | Hellenic Breast Surgeons SocietyOTHER | 1 | Dec 18, 2008 | clinicaltrials |
| NCT00403988 | Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (Herceptin®) in Advanced Breast Carcinoma | terminated | Phase 2 | 40 | American University of Beirut Medical CenterOTHER | 1 | Nov 4, 2008 | clinicaltrials |
| NCT00303615 | Androgen Therapy for Management of Estrogen/Progesterone Receptor Negative ER(-)PR(-) Metastatic Breast Cancer | terminated | Phase 2 | 5 | Legacy Health SystemOTHER | 1 | Oct 20, 2008 | clinicaltrials |
| NCT00027131 | Vaccination Against High Risk Breast Cancer Using Tumor Derived Heat Shock Protein 70 | terminated | Phase 1 / Phase 2 | 15 | UConn HealthOTHER | 1 | Oct 8, 2008 | clinicaltrials |
| NCT00156260 | Feasibility Study of Evaluating Breast Cancer Patients With Ductal Lavage | terminated | — | 88 | University of Michigan Rogel Cancer CenterOTHER | 1 | Oct 8, 2008 | clinicaltrials |
| NCT00162812 | Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubicin(TOP) | terminated | Phase 2 | 338 | Jules Bordet InstituteOTHER | 1 | Jul 18, 2008 | clinicaltrials |
| NCT00461344 | Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer | terminated | Phase 2 | 20 | SanofiINDUSTRY | 0 | Apr 3, 2008 | clinicaltrials |
| NCT00249301 | A Study of MLN8054 in Patients With Advanced Solid Tumors | terminated | Phase 1 | 63 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 1, 2008 | clinicaltrials |
| NCT00146029 | Companion Pharmacogenetic Study to UMCC 9900/9901 | terminated | — | — | University of Michigan Rogel Cancer CenterOTHER | 1 | Mar 26, 2008 | clinicaltrials |
| NCT00197925 | Dendritic Cell Based Therapy of Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 40 | Herlev HospitalOTHER | 1 | Jan 3, 2008 | clinicaltrials |
| NCT00165581 | High Dose Rate Intracavitary Brachytherapy as the Sole Method of Radiation Therapy for Breast Carcinoma | terminated | N/A | 15 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 21, 2007 | clinicaltrials |
| NCT00215748 | Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly Docetaxel | terminated | Phase 2 | 40 | Geriatric Oncology ConsortiumOTHER | 1 | Nov 16, 2007 | clinicaltrials |
| NCT00267553 | Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer | terminated | Phase 3 | 200 | Intarcia TherapeuticsINDUSTRY | 4 | Sep 10, 2007 | clinicaltrials |
| NCT00097344 | The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer | terminated | Phase 3 | 842 | Intarcia TherapeuticsINDUSTRY | 5 | Aug 23, 2007 | clinicaltrials |
| NCT00225056 | Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma | terminated | Phase 2 | 43 | Oncology Specialties, AlabamaOTHER | 1 | Apr 20, 2007 | clinicaltrials |
| NCT00099281 | DPPE in Combination With Epirubicin and Cyclophosphamide in the Treatment of Breast Cancer | terminated | Phase 3 | 700 | YM BioSciencesINDUSTRY | 1 | Feb 28, 2007 | clinicaltrials |
| NCT00287482 | Essiac (ESIAK) Versus Placebo to Improve Quality of Life in Transition in Women With Breast or Ovarian Cancer. | terminated | N/A | 20 | Women and Infants Hospital of Rhode IslandOTHER | 1 | Feb 12, 2007 | clinicaltrials |
| NCT00123877 | Study of GPX-100 in the Treatment of Metastatic Breast Cancer | terminated | Phase 2 | 40 | Gem PharmaceuticalsINDUSTRY | 2 | Jan 9, 2007 | clinicaltrials |
| NCT00210028 | Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer | terminated | Phase 2 | 40 | Institut Claudius RegaudOTHER | 1 | Nov 14, 2006 | clinicaltrials |
| NCT00395655 | Hydralazine and Valproate Added to Chemotherapy for Breast Cancer | terminated | Phase 2 | 43 | National Institute of CancerologíaOTHER_GOV | 1 | Nov 3, 2006 | clinicaltrials |
Data updated 23 days agoSource updated Aug 10, 2009source: clinicaltrials